Subramanian Natesan, Sai H.S. Boddu, Venkateshwaran Krishnaswami & Moyad Shahwan. (2020) The Role of Nano-ophthalmology in Treating Dry Eye Disease. Pharmaceutical Nanotechnology 8:4, pages 258-289.
Crossref
Yang Liu, Yanan Wang, Jinlong Yang, Hua Zhang & Li Gan. (2019) Cationized hyaluronic acid coated spanlastics for cyclosporine A ocular delivery: Prolonged ocular retention, enhanced corneal permeation and improved tear production. International Journal of Pharmaceutics 565, pages 133-142.
Crossref
Vijay Kumar Singh & Raj K. Keservani. 2017. Materials Science and Engineering. Materials Science and Engineering
1358
1383
.
Vijay Kumar Singh & Raj K. Keservani. 2017. Pharmaceutical Sciences. Pharmaceutical Sciences
128
153
.
Vijay Kumar Singh & Raj K. Keservani. 2017. Novel Approaches for Drug Delivery. Novel Approaches for Drug Delivery
364
389
.
Priyanka Agarwal & Ilva D. Rupenthal. (2016) In vitro and ex vivo corneal penetration and absorption models. Drug Delivery and Translational Research 6:6, pages 634-647.
Crossref
José AriasCornelia Vasile, Ana Oprea, Manuela Nistor & Anca-Maria Cojocariu. 2014. Nanotechnology and Drug Delivery, Volume One. Nanotechnology and Drug Delivery, Volume One
28
80
.
Christoph Luschmann, Joerg Tessmar, Simon Schoeberl, Olaf Strau, Karl Luschmann & Achim Goepferich. (2014) Self-Assembling Colloidal System for the Ocular Administration of Cyclosporine A. Cornea 33:1, pages 77-81.
Crossref
Christoph Luschmann, Joerg Tessmar, Simon Schoeberl, Olaf Strauss, Carsten Framme, Karl Luschmann & Achim Goepferich. (2013) Developing an in situ nanosuspension: A novel approach towards the efficient administration of poorly soluble drugs at the anterior eye. European Journal of Pharmaceutical Sciences 50:3-4, pages 385-392.
Crossref
Marta Rodriguez-Aller, Davy Guillarme, Mohamed El Sanharawi, Francine Behar-Cohen, Jean-Luc Veuthey & Robert Gurny. (2013) In vivo distribution and ex vivo permeation of cyclosporine A prodrug aqueous formulations for ocular application. Journal of Controlled Release 170:1, pages 153-159.
Crossref
Burçin Yavuz, Sibel Bozdağ Pehlivan & Nurşen Ünlü. (2012) An Overview on Dry Eye Treatment: Approaches for Cyclosporin A Delivery. The Scientific World Journal 2012, pages 1-11.
Crossref
P Hervella, G Lollo, F Oyarzun-Ampuero, G Rivera, D Torres & M Alonso. 2011. Nanocomposite Particles for Bio-Applications. Nanocomposite Particles for Bio-Applications
45
67
.
Esther Eljarrat-Binstock, Jacob Pe’er & Abraham J. Domb. (2010) New Techniques for Drug Delivery to the Posterior Eye Segment. Pharmaceutical Research 27:4, pages 530-543.
Crossref
Esther Eljarrat-Binstock, Faik Orucov, Yanir Aldouby, Joseph Frucht-Pery & Abraham J. Domb. (2008) Charged nanoparticles delivery to the eye using hydrogel iontophoresis. Journal of Controlled Release 126:2, pages 156-161.
Crossref
Catarina Pinto Reis, Ronald J. Neufeld, António J. Ribeiro & Francisco Veiga. (2006) Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nanomedicine: Nanotechnology, Biology and Medicine 2:2, pages 53-65.
Crossref
N. Ubrich, C. Schmidt, R. Bodmeier, M. Hoffman & P. Maincent. (2005) Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles. International Journal of Pharmaceutics 288:1, pages 169-175.
Crossref
F. Chast, F. Lemare, J.-M. Legeais, R. Batista, C. Bardin & G. Renard. (2004) Préparation d’un collyre de ciclosporine à 2 %. Journal Français d'Ophtalmologie 27:6, pages 567-576.
Crossref
E Fattal, D Labarre & C Vauthier. 2003. Tissue Engineering And Novel Delivery Systems. Tissue Engineering And Novel Delivery Systems.
F Lallemand, O Felt-Baeyens, K Besseghir, F Behar-Cohen & R Gurny. (2003) Cyclosporine A delivery to the eye: A pharmaceutical challenge. European Journal of Pharmaceutics and Biopharmaceutics 56:3, pages 307-318.
Crossref
Christine Vauthier, Catherine Dubernet, Elias Fattal, Huguette Pinto-Alphandary & Patrick Couvreur. (2003) Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Advanced Drug Delivery Reviews 55:4, pages 519-548.
Crossref
Murali Kothuri, Swathi Pinnamaneni, Nandita Das & Sudip Das. 2003. Ophthalmic Drug Delivery Systems, Second Edition. Ophthalmic Drug Delivery Systems, Second Edition
437
466
.
Francesca Maestrelli, Paola Mura, Angela Casini, Francesco Mincione, Andrea Scozzafava & Claudiu T. Supuran. (2002) Cyclodextrin Complexes of Sulfonamide Carbonic Anhydrase IOnhibitors As Long‐lasting Topically Acting Antiglaucoma Agents. Journal of Pharmaceutical Sciences 91:10, pages 2211-2219.
Crossref
G Barratt, G Couarraze, P Couvreur, C Dubernet, E Fattal, R Gref, D Labarre, P Legrand, G Ponchel & C Vauthier. 2001. Polymeric Biomaterials, Revised and Expanded. Polymeric Biomaterials, Revised and Expanded.
M. Vetrugno, G.M. Quaranta, A. Maino & L. Cardia. (2018) A Randomized, Comparative Study of Fluorometholone 0.2% and Fluorometholone 0.1% Acetate after Photorefractive Keratectomy. European Journal of Ophthalmology 10:1, pages 39-45.
Crossref
Chrystèle Le Bourlais, Liliane Acar, Hosein Zia, Pierre A. Sado, Thomas Needham & Roger Leverge. (1998) Ophthalmic drug delivery systems—Recent advances. Progress in Retinal and Eye Research 17:1, pages 33-58.
Crossref